Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K D Smith

Showing results (211-220 of 211) with videos related to

Pageof 22
Sort By:
You have reached the last page of results.This site can display upto 211 results.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 11, 2012
Neoadjuvant cetuximab, twice-weekly gemcitabine, and intensity-modulated radiotherapy (IMRT) in patients with pancreatic adenocarcinomaJ M Pipas, B I Zaki, M M McGowan, et al.
Pageof 22

Showing results (211-220 of 211) with videos related to

Sort By:
Pageof 22
You have reached the last page of results.This site can display upto 211 results.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 11, 2012
Neoadjuvant cetuximab, twice-weekly gemcitabine, and intensity-modulated radiotherapy (IMRT) in patients with pancreatic adenocarcinomaJ M Pipas, B I Zaki, M M McGowan, et al.
Pageof 22